Bright Minds Biosciences Inc. · CSE:DRUG
Janus Henderson Group PLC reported a 11.60% stake in Bright Minds Biosciences Inc. (Schedule 13G)
Event Jan 31, 2025 · Filed Feb 7, 2025
Janus Henderson Group PLC reported a 11.60% stake in Bright Minds Biosciences Inc., 804,976 shares, as a passive investor on Jan 31, 2025. Filed Feb 7, 2025 (Schedule 13G).
- Stake
- 11.60%
- Shares
- 804,976
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 11.60% | 804,976 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 10.40% | 719,574 |
Source
Related
- Bright Minds Biosciences Inc.
- Janus Henderson Group PLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Apr 7, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · May 12, 2026